Rebalix
Logo VanguardVanguard · sheet of 5 September 2026
ETF sheet · official issuer and register data

Vanguard Russell 2000 U.S. Small-Cap UCITS ETF USD Acc

VRSA · IE000GTBEXG4 · USD · domicile Ireland
Equity · United StatesSFDR art. 6 (inferred)
Index tracked: Russell 2000 Index
TER
0.20%+ trans. 0.02%
Fund size
5 m EUR
Tracking difference
not computable
🇮🇹 tax rate
26.00%equity
Replication
Physical
Income
Accumulating
Launch 7 Jul 2026 · costs from the KID as of 2 Sept 2026 · 1,956 securities held · 10 venues (ESMA register)

The fund’s objective — in the issuer’s words

From the Key Information Document (KID) · 4 Aug 2026
In seeking to achieve its investment objective, the Fund aims to provide a return which, before the application of fees and expenses, is similar to the return of the Index. The Fund employs a passive management – or indexing – investment approach, through physical acquisition of securities, and seeks to track the performance of the Russell 2000® Index (the “Index”). The Index measures the performance of the small-cap segment of the US equity universe. The Index is a subset of the Russell 3000® Index which is designed to represent approximately 98% of the…

Performance since series start (in euro) — base 100

7 Jul 20263 Sept 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
1029798
High 102 (14 Aug 2026) · low 97 (1 Sept 2026) · last 98. Past performance is not indicative of future results.

Returns in euro

1 yearseries too young
3 yearsseries too young
5 yearsseries too young
10 yearsseries too young
Since series start−1.9%

Risk · 1 / 3 / 5 years

Volatility (ann.)
Max drawdown
Sharpe
Sortino
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · VRSA · IE000GTBEXG41
RebalixVRSA · IE000GTBEXG4 · sheet of 5 September 2026

Tracking difference — year by year

Fund minus index, complete calendar years
Not honestly computable: index series not published by the issuer

Holdings

Portfolio as declared by the issuer · 31 Jul 2026 · 1,956 securities · top-10 weight = 3.2%
Top holdingsWeight
Hut 8 Corp0.4%
Moog Inc0.4%
UMB Financial Corp0.4%
Cytokinetics Inc0.3%
Viasat Inc0.3%
BrightSpring Health Services Inc0.3%
Glaukos Corp0.3%
CareTrust REIT Inc0.3%
Old National Bancorp/IN0.3%
Brinker International Inc0.3%
Countries (% of fund)
United States99.2%Other0.9%Canada0.8%United Kingdom0.3%Brazil0.2%
Sectors (% of fund)
Health Care19.8%Financials18.9%Industrials16.0%Consumer Discretionary11.8%Technology10.8%

Listing venues

ESMA register (FIRDS) and official exchange lists
VRSA · Borsa Italiana (ETFplus), Euronext Amsterdam
V2SA · Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange, Xetra (Deutsche Börse)
+ 8 unmapped venues (MTF, RFQ, professional)

Official documents

Clickable links in the PDF
KID · fund-docs.vanguard.com/ie000gtbexg4_priipskid_en.pdf
Factsheet · fund-docs.vanguard.com/Russell_2000_U.S._Small-Cap_UCITS_ETF_USD_Acc_E
Prospectus · fund-docs.vanguard.com/etf-prospectus-en.pdf
The live sheet, always up to date
rebalix.com/en/etf/IE000GTBEXG4
Series, distributions, holdings and documents refresh daily.
Sheet produced on 5 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.

Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.

Rebalix · VRSA · IE000GTBEXG42